Jubilant Life#39;s performance would be driven by market share gains in key radiopharmaceutical products, a ramp-up in CMO business, capacity additions in finished dosages Life Science Chemical segment and opportunities from the supply of ethanol to government, IDBI Capital saidTroubles brew at this pharmacy but analysts see up to 100% return in a year
Jubilant Life#39;s performance would be driven by market share gains in key radiopharmaceutical products, a ramp-up in CMO business, capacity additions in finished dosages Life Science Chemical segment and opportunities from the supply of ethanol to government, IDBI Capital said
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.
No comments:
Post a Comment